| abstract |
The invention relates to novel arylalkyl or arylalkyl substituted oxiran carboxylic acids of general formula(I), wherein Ar, R<3>, Y and n have the meaning cited in the description, as well as to medicaments containing them and the use thereof in the treatment and prophylaxis of the diseases named in Claim 3 based on disturbances of glucose and/or fat metabolism, e.g. diabetes type 2 and other insulin-resistant conditions. |